Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Common Stock · CUSIP: 803607100
Event date: 2025-06-30
- Filing-level shares
- 524,146.00
- Percent of class
- 0.5%
- Capital International Investors
Shares: 524,146.00 · Class: 0.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-25-000112
- Form type
- SCHEDULE 13G/A
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership